Global Cancer Registry Software Market
Cancer Registry Software Market- By Type, Deployment Model, Database, Functionality, End-User, and Region.
The Global Cancer Registry Software Market is valued at USD 56.42 Billion in the year 2022 and is projected to reach a value of USD 108.38 Billion by the year 2030. The Global Market is anticipated to grow exhibiting a Compound Annual Growth Rate (CAGR) of 8.50% over the forecast period.
Cancer Registry Software Market Size, 2022 To 2030 (USD Billion)
Cancer Registry Software aids in the gathering of information about cancer patients. It is a computerized database that organizes, manages, and stores cancer patient data using software solutions. The use of Cancer Registry Software is expected to develop as a result of various benefits, including effective workflow management, automated case registries, and the rising cancer incidence. In addition, many government organizations are taking steps to help construct cancer registries, which is projected to drive market growth. The widespread adoption of electronic health records (EHR) and other e-health technologies such as e-Prescribing, telemedicine, and others is driving the market's growth. In addition, cloud-based patient registry solutions have developed as an effective tool that provides end-users with improved data accessibility and real-time analysis while being user-friendly.
Report Coverage & Deliverables
- Real-Time Data Updates:
- Competitor Benchmarking
- Market Trends Heatmap
- Custom Research Queries
- Market Sentiment Analysis
- Demographic and Geographic Insights
Furthermore, the growing geriatric population will boost the worldwide Cancer Registry Software Market over the forecast period. The government can also use this software to keep track of patients in a certain location or region. As a result, this factor contributes to the growth of the worldwide Cancer Registry Software Market.
Governments all across the world are constantly adopting steps to combat cancer. Every year, cancer kills a considerable number of people. The government is also partnering with healthcare facilities and research institutes to produce cancer therapies. As a result, the market's growth prospects are bright. As a result, expanding government initiatives are offering lucrative chances for the Cancer Registry Software industry to flourish. However, the development of innovative solutions has been impeded by the lack of connectivity between EHR systems and independent cancer patient registry software. These types of data sharing difficulties are expected to continue to require manual processes for importing or exporting patient records between different EHR systems until a universal health information exchange system is built throughout a country/region. As a result, cancer patient registry software suppliers have a significant problem due to the extensive use of EHRs that are not entirely compatible.
The Cancer Registry Software Market is segmented on the basis of Type, Deployment Model, Database, Functionality and End-User. On the basis of Type, the market is segmented into Standalone Software and Integrated Software. On the basis of Deployment Model, the market is segmented into On-Premise and Cloud-Based. On the basis of Database, the market is segmented into Commercial Databases and Public Databases. On the basis of Functionality, the market is segmented into Cancer Reporting to Meet State & Federal Regulations, Patient Care Management, Product Outcome Evaluation, and Medical Research and Clinical Studies. On the basis of End-User, the market is segmented into Government Organizations & Third-party Administrators (TPAS), Hospitals & Medical Practices, Pharmaceutical, Biotechnology, & Medical Device Companies, Private Payers, and Research Centers.
Below tree is interactive. You can click the nodes to get more information.
Based on Type:
On the basis of Type, the market is segmented into Standalone Software and Integrated Software. Because of the changing environment of the healthcare industry, the need to streamline and optimize workflows, and the goal to minimize physician workloads, the use of integrated software is on the rise. Furthermore, market growth is being aided by factors such as the government's increased focus on population health management, coordinated care, and cost-cutting.
Based on End-User:
Research centers primarily employ cancer patient registration software to track patients who are eligible for clinical trials. Researchers mostly use the registry's data for product development. Many research institutions have created their own databases to track cancer patients of various sorts. Furthermore, some research institutes partner with hospitals and other organizations to create cancer patient registries.
North America Region Dominates the Cancer Registry Software Market with the Largest Share
North America is projected to acquire the largest market share with a share of 37.10%. The cancer patient registry software industry is based in North America. North America dominated the market in 2021, and this trend is likely to continue throughout the projection period. The high burden of cancer, government funding initiatives to encourage the development of cancer registries, high investments in healthcare IT, the presence of significant Cancer Registry Software development market players, and the high adoption rate of these solutions in the region all contribute to North America's larger share of the Cancer Registry Software Market.
Key players operating in the Global Cancer Registry Software Market include- Elekta (Sweden), Electronic Registry Systems Inc. (US), Onco Inc. (US), C/NET Solutions (US), Rocky Mountain Cancer Data Systems (US), McKesson Corporation (US) and others.
Segmentation of the Global Cancer Registry Software Market:
- Standalone Software
- Integrated Software
- Commercial Databases
- Public Databases
- Cancer Reporting to Meet State & Federal Regulations
- Patient Care Management
- Product Outcome Evaluation
- Medical Research and Clinical Studies
- Government Organizations & Third-Party Administrators (TPAS)
- Hospitals & Medical Practices
- Pharmaceutical, Biotechnology, & Medical Device Companies
- Private Payers
- Research Centers
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
|Regions & Countries Covered
- North America - (U.S., Canada, Mexico)
- Europe - (U.K., France, Germany, Italy, Spain, Rest Of Europe)
- Asia Pacific - (China, Japan, India, South Korea, South East Asia, Rest Of Asia Pacific)
- Latin America - (Brazil, Argentina, Rest Of Latin America)
- Middle East & Africa - (GCC Countries, South Africa, Rest Of Middle East & Africa)
- Elekta (Sweden)
- Electronic Registry Systems Inc. (US)
- Onco Inc. (US)
- C/NET Solutions (US)
- Rocky Mountain Cancer Data Systems (US)
- McKesson Corporation (US)
|Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST
analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market
attractiveness analysis by segments and North America, company market share analysis, and COVID-19
Pricing and purchase options
|Avail of customized purchase options to meet your exact research needs. Explore purchase options